R
Richard R. Watkins
Researcher at Cleveland Clinic
Publications - 17
Citations - 933
Richard R. Watkins is an academic researcher from Cleveland Clinic. The author has contributed to research in topics: Antibiotic resistance & Carbapenem-resistant enterobacteriaceae. The author has an hindex of 9, co-authored 17 publications receiving 630 citations. Previous affiliations of Richard R. Watkins include Northeast Ohio Medical University.
Papers
More filters
Journal ArticleDOI
Colistin Versus Ceftazidime-Avibactam in the Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae
David van Duin,Judith J. Lok,Michelle Earley,Eric Cober,Sandra S. Richter,Federico Perez,Federico Perez,Robert A. Salata,Robert C. Kalayjian,Richard R. Watkins,Richard R. Watkins,Yohei Doi,Keith S Kaye,Vance G. Fowler,David L. Paterson,Robert A. Bonomo,Robert A. Bonomo,Scott R. Evans +17 more
TL;DR: Ceftazidime-avibactam may be a reasonable alternative to colistin in the treatment of K. pneumoniae carbapenemase-producing CRE infections and require confirmation in a randomized controlled trial.
Journal ArticleDOI
Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae: Laboratory Detection and Impact on Mortality.
Laura J. Rojas,Laura J. Rojas,Madiha Salim,Eric Cober,Sandra S. Richter,Federico Perez,Federico Perez,Robert A. Salata,Robert C. Kalayjian,Richard R. Watkins,Richard R. Watkins,S H Marshall,Susan D. Rudin,T. Nicholas Domitrovic,Andrea M. Hujer,Kristine M. Hujer,Yohei Doi,Keith S. Kaye,Scott R. Evans,Vance G. Fowler,Robert A. Bonomo,David van Duin +21 more
TL;DR: The apparent polyclonal nature of the isolates suggests de novo emergence of ColR in this cohort as the primary factor driving ColR, and mortality was increased in patients with ColR isolates.
Journal ArticleDOI
Raising concerns about the Sepsis-3 definitions
Massimo Sartelli,Yoram Kluger,Luca Ansaloni,Timothy Craig Hardcastle,Jordi Rello,Richard R. Watkins,Richard R. Watkins,Matteo Bassetti,Eleni Giamarellou,Federico Coccolini,Fikri M. Abu-Zidan,A R K Adesunkanmi,Goran Augustin,Gian L. Baiocchi,Miklosh Bala,Oussema Baraket,Marcelo A. Beltrán,Asri Che Jusoh,Zaza Demetrashvili,Belinda De Simone,Hamilton Petry de Souza,Yunfeng Cui,R. Justin Davies,Sameer Dhingra,Jose J. Diaz,Salomone Di Saverio,Agron Dogjani,Mutasim M. Elmangory,Mushira Enani,Paula Ferrada,Gustavo Pereira Fraga,Sabrina Frattima,Wagih Ghnnam,Carlos Augusto Gomes,Souha S. Kanj,Aleksandar Karamarkovic,Jakub Kenig,Faryal Khamis,Vladimir Khokha,Kaoru Koike,Kenneth Y.Y. Kok,Arda Isik,Francesco M. Labricciosa,Rifat Latifi,Jae G. Lee,Andrey Litvin,Gustavo M. Machain,Ramiro Manzano-Nunez,Piotr Major,Sanjay Marwah,Michael McFarlane,Ziad A. Memish,Cristian Mesina,Ernest E. Moore,Frederick A. Moore,Noel Naidoo,Ionut Negoi,Richard Ofori-Asenso,Iyiade Olaoye,Carlos A. Ordoñez,Mouaqit Ouadii,Ciro Paolillo,Edoardo Picetti,Tadeja Pintar,Alfredo Ponce-de-León,Guntars Pupelis,Tarcisio Reis,Boris Sakakushev,Hossein Samadi Kafil,Norio Sato,Jay N Shah,Boonying Siribumrungwong,Peep Talving,Cristian Tranà,Jan Ulrych,Kuo Ching Yuan,Fausto Catena +76 more
TL;DR: The Global Alliance for Infections in Surgery appreciates the great effort of the task force who derived and validated the Sepsis-3 definitions and considers the new definitions an important step forward in the evolution of the understanding of sepsis.
Journal ArticleDOI
Antimicrobial resistance in methicillin-resistant Staphylococcus aureus to newer antimicrobial agents.
TL;DR: The mechanisms, prevalence, and clinical importance of resistance to antibiotics licensed in the past 20 years that target MRSA, as well as new drugs in the pipeline which are likely to be licensed soon are delineated.
Journal ArticleDOI
The Pitt Bacteremia Score Predicts Mortality in Nonbacteremic Infections.
Heather Henderson,Courtney L Luterbach,Eric Cober,Sandra S. Richter,Robert A. Salata,Robert C. Kalayjian,Richard R. Watkins,Richard R. Watkins,Yohei Doi,Keith S Kaye,Scott R. Evans,Vance G. Fowler,Robert A. Bonomo,Anthony D. Harris,Sonia Napravnik,David van Duin +15 more
TL;DR: It is validated that the PBS and qPitt score can be used as reliable predictors of mortality in non-bacteremia CRE infections.